• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Chase Corporation (Amendment)

    9/11/23 8:23:55 AM ET
    $CCF
    Building Products
    Consumer Discretionary
    Get the next $CCF alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.22 CHASE CORP COMMON STOCK Cusip #16150R104 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #16150R104 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 141 Item 6: 0 Item 7: 263 Item 8: 0 Item 9: 263 Item 11: 0.002% Item 12: HC Cusip #16150R104 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 263 Item 8: 0 Item 9: 263 Item 11: 0.002% Item 12: IN Item 1(a). Name of Issuer: CHASE CORP Item 1(b). Address of Issuer's Principal Executive Offices: 295 University Ave Westwood, MA 02090 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 16150R104 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 263 (b) Percent of Class: 0.002% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 263 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof, the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following (X). Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of CHASE CORP. No one other person's interest in the COMMON STOCK of CHASE CORP is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. September 8, 2023 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification Fidelity Management & Research Company LLC IA Strategic Advisers LLC IA Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on September 8, 2023, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of CHASE CORP at August 31, 2023. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Get the next $CCF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CCF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CCF
    SEC Filings

    See more
    • SEC Form 15-12G filed by Chase Corporation

      15-12G - CHASE CORP (0000830524) (Filer)

      11/27/23 6:01:05 AM ET
      $CCF
      Building Products
      Consumer Discretionary
    • SEC Form EFFECT filed by Chase Corporation

      EFFECT - CHASE CORP (0000830524) (Filer)

      11/17/23 12:15:07 AM ET
      $CCF
      Building Products
      Consumer Discretionary
    • SEC Form S-8 POS filed by Chase Corporation

      S-8 POS - CHASE CORP (0000830524) (Filer)

      11/15/23 5:23:59 PM ET
      $CCF
      Building Products
      Consumer Discretionary

    $CCF
    Leadership Updates

    Live Leadership Updates

    See more
    • Inogen Names Michael Bourque as New Chief Financial Officer

      Inogen, Inc. (NASDAQ:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Michael Bourque as Chief Financial Officer, effective March 4, 2024. Mr. Bourque has served as Treasurer and Chief Financial Officer of Chase Corporation (NYSE:CCF) now owned by KKR & Co. Inc. He succeeds Interim Chief Financial Officer Mike Sergesketter, who will remain in an advisory role during the transition. Mr. Bourque has served as Chief Financial Officer and Treasurer of Chase Corporation since 2021. He also served as Chief Financial Officer of Keystone Dental, Senior Vice President, Chief Financial Officer and Treasu

      1/24/24 4:00:00 PM ET
      $CCF
      $INGN
      Building Products
      Consumer Discretionary
      Industrial Specialties
      Health Care
    • Chase Corporation Appoints Ellen Rubin to its Board of Directors

      Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, announced on July 14, 2022 that the Board of Directors elected Ellen Rubin to the Board, as an independent director, effective immediately. Additionally, she will serve as a member of Chase's Audit Committee. Peter Chase, Chairman of the Board, commented "We are thrilled to be adding Ellen Rubin's leadership, industry knowledge, and expertise to our Board of Directors as we continue to expand our business, drive scale, and deliver against our proven growth strategy. Ms. Rubin brings to our Board an extensi

      7/20/22 5:23:00 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Chase Corporation Announces Fiscal First Quarter 2021 Results

      WESTWOOD, Mass.--(BUSINESS WIRE)--Chase Corporation (NYSE American: CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the quarter ended November 30, 2020, the first quarter of its fiscal year 2021. Fiscal First Quarter Key Highlights Total Revenue of $67.2 million, up compared to $66.8 million in the prior year Gross Margin of 41%, up compared to 37% in the prior year Net Income of $10.8 million, up compared to $7.4 million in the prior year Adjusted EBITDA of $18.1 million, up compared to $14.7 million in the prior year

      1/7/21 4:05:00 PM ET
      $CCF
      Building Products
      Consumer Discretionary

    $CCF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Chase Corporation (Amendment)

      SC 13G/A - CHASE CORP (0000830524) (Subject)

      11/22/23 4:25:56 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Chase Corporation (Amendment)

      SC 13G/A - CHASE CORP (0000830524) (Subject)

      9/11/23 8:23:55 AM ET
      $CCF
      Building Products
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Chase Corporation (Amendment)

      SC 13G/A - CHASE CORP (0000830524) (Subject)

      9/8/23 9:17:41 AM ET
      $CCF
      Building Products
      Consumer Discretionary

    $CCF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Inogen Names Michael Bourque as New Chief Financial Officer

      Inogen, Inc. (NASDAQ:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Michael Bourque as Chief Financial Officer, effective March 4, 2024. Mr. Bourque has served as Treasurer and Chief Financial Officer of Chase Corporation (NYSE:CCF) now owned by KKR & Co. Inc. He succeeds Interim Chief Financial Officer Mike Sergesketter, who will remain in an advisory role during the transition. Mr. Bourque has served as Chief Financial Officer and Treasurer of Chase Corporation since 2021. He also served as Chief Financial Officer of Keystone Dental, Senior Vice President, Chief Financial Officer and Treasu

      1/24/24 4:00:00 PM ET
      $CCF
      $INGN
      Building Products
      Consumer Discretionary
      Industrial Specialties
      Health Care
    • Chase Corporation Announces Completion of Acquisition by KKR and Welcomes Lance Reisman as Chairman of the Board of Directors

      Chase Corporation ("Chase" or the "Company"), a leading global manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced the successful completion of its acquisition by affiliates of KKR, a leading global investment firm, for $127.50 per share. As a result of the completion of the transaction, Chase common stock has ceased trading and will no longer be listed on the NYSE American. "Today represents an important milestone for Chase in our journey to better serve our customers through strategic growth and innovation," said Adam Chase, President and Chief Executive Officer of Chase. "From the beginning, KKR was a strong cultural fit

      11/15/23 9:23:00 AM ET
      $CCF
      $KKR
      Building Products
      Consumer Discretionary
      Investment Managers
      Finance
    • Chase Corporation Announces October 6, 2023 Special Meeting Results

      Chase Corporation ("Chase" or the "Company") (NYSE:CCF), a leading global manufacturer of protective materials for high-reliability applications across diverse market sectors, held a special meeting of shareholders earlier today (the "Special Meeting") at which Chase shareholders approved the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement") dated July 21, 2023 by and among Chase, Formulations Parent Corporation ("Parent") and Formulations Merger Sub Corporation ("Merger Sub"). Pursuant to the Merger Agreement, Merger Sub will merge with and into Chase, with Chase surviving as a wholly owned subsidiary of Parent (the "Merger"). Parent and Merger

      10/6/23 4:18:00 PM ET
      $CCF
      $KKR
      Building Products
      Consumer Discretionary
      Investment Managers
      Finance

    $CCF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Bourque Michael J. returned 9,738 units of Chase Corporation Common Stock to the company, closing all direct ownership in the company (SEC Form 4)

      4 - CHASE CORP (0000830524) (Issuer)

      11/15/23 7:25:46 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Debyle Thomas D. returned 3,886 units of Chase Corporation Common Stock to the company, closing all direct ownership in the company (SEC Form 4)

      4 - CHASE CORP (0000830524) (Issuer)

      11/15/23 7:22:37 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Chase Peter R returned 840,519 units of Chase Corporation Common Stock to the company, closing all direct ownership in the company (SEC Form 4)

      4 - CHASE CORP (0000830524) (Issuer)

      11/15/23 7:20:32 PM ET
      $CCF
      Building Products
      Consumer Discretionary

    $CCF
    Financials

    Live finance-specific insights

    See more
    • Chase Corporation Announces Fiscal First Quarter 2023 Results

      Revenue Increased 37.2% to $103 Million Year Over Year NuCera Business Integration Progressing, Elevating Company-Wide Results While Expanding Geographic Footprint and Specialized Product Offerings Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the first fiscal quarter ended November 30, 2022. Fiscal First Quarter Financial and Recent Operational Highlights Total Revenue grew 37.2% to $103 million, primarily attributed to inorganic growth from the NuCera business which was acquired in the first month of Q1 FY23

      1/5/23 5:01:00 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Chase Corporation Announces Fiscal Fourth Quarter 2022 Results

      Revenue Increased by 12.7% to $88 Million in Q4 FY22 compared to Q4 FY21 Gross Margin improved from first half of fiscal 2022 ending the year at 37.8% Declares Dividend of $1.00 Per Share Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, announced financial results for the fourth fiscal quarter ended August 31, 2022. The Company also announced a cash dividend of $1.00 per share to shareholders of record on November 30, 2022, payable on December 9, 2022. Fiscal Fourth Quarter Financial and Recent Operational Highlights Total Revenue grew 12.7% to $88

      11/10/22 8:59:00 AM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Chase Corporation Acquires NuCera Solutions

      Transformative acquisition expands the Company's suite of specialty polymers and attractive polymerization technologies, advancing Chase Corp's portfolio of products, customer reach and strategic growth trajectory Chase Corporation (NYSE:CCF), a leading global manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced that it has entered into a definitive agreement to acquire NuCera Solutions, ("NuCera" or the "Company") from SK Capital (a private equity firm headquartered in New York). NuCera is a recognized global leader in the production and development of highly differentiated specialty polymers and polymerization technologies

      7/18/22 6:04:00 PM ET
      $CCF
      Building Products
      Consumer Discretionary